MPN Quality Initiatives

Myeloproliferative neoplasms (MPNs) bring a symptom burden that may require care coordination & close monitoring. A strong multidisciplinary approach may impact shared decision-making and patient engagement. CANCER BUZZ speaks with Andrew Kuykendall, MD, and Katherine Mast, BSN, RN, both from a major cancer center, about the impact of multidisciplinary coordination on patient care and outcomes for patients with MPNs. https://lnkd.in/eY_NryJA #ACCC #MPNs This information is intended for US Population-Health Decision Makers or similar entities at hospitals and US oncology practices. © 2023, Incyte. MAT-HEM-03569 12/23

Are you doing these three critical things to generate the best outcomes for your patients with myeloproliferative neoplasms (MPNs)? A physician thought leader shares three ways to better manage patients with MPNs, including symptom assessment, risk stratification at diagnosis, and spleen assessment. Dr. Robyn Scherber, Assistant Professor of Medicine at the University of Texas Health Science Center at San Antonio, explains the importance of educating your full care team about MPN-related symptom recognition, assessing a patient’s risk level at diagnosis, and conducting a spleen palpation as part of every exam. Learn more about quality care in patients with MPNs at: https://lnkd.in/guKGXf6k The elements of the Quality Initiative described have not been validated or approved for securing accreditation or reimbursement, nor has the information been supported or endorsed by any entity for these purposes. This information is intended for US Population-Health Decision Makers or similar entities at hospitals and US oncology practices. © 2024, Incyte. MAT-HEM-03944 07/24

Are you properly assessing risk factors in your patients with myelofibrosis (MF)? Watch to learn how to implement a Quality Initiative (QI) for patients with MF, including a step-by-step guide for risk stratification, an important component of managing patients with MF. Julianne Orr, PharmD, BCOP, an Oncology and Clinical Pharmacist at Indiana University Health, highlights the importance of risk stratification and shares a detailed, stepwise approach to assessing risk factors in patients with MF. Learn more about quality care in patients with MF at: https://lnkd.in/guKGXf6k This information is intended for US Population-Health Decision Makers or similar entities at hospitals and US oncology practices. © 2024, Incyte. MAT-HEM-03943 07/24

Quality Initiatives (QIs) can have a real-world impact on patients with high-risk polycythemia vera (PV). Hear an insider’s view and learn how a practice team successfully implemented a QI to improve patient care in PV. Kathy Oubre, CEO of Pontchartrain Cancer Center, and her staff share best practices on how to implement a QI to improve patient care in PV. Hear their first-hand advice about the benefits of role identification, the importance of provider buy-in and feedback on workflows, and the power of a collaborative care approach. Learn more about quality care in patients with PV at: https://lnkd.in/guKGXf6k This information is intended for US Population-Health Decision Makers or similar entities at hospitals and US oncology practices. © 2024, Incyte. MAT-HEM-03942 07/24

Hear what community practices need to know about treating patients with MPNs quickly & the impact that can have on patient outcomes. MPNs are a group of progressive blood cancers that can develop into more serious hematological diseases. CANCER BUZZ speaks with Srdan Verstovsek, MD, PhD, Professor of Medicine & hematologist oncologist, about when to begin therapeutic care for MPNs and the urgency of treatment. https://lnkd.in/eyRaGM-q This information is intended for US Population-Health Decision Makers or similar entities at hospitals and US oncology practices. © 2023, Incyte. MAT-HEM-03578 10/23

Hear why community practices need to monitor symptoms carefully in patients with myeloproliferative neoplasms (MPNs), & about a tool that can help assess symptoms more accurately and help care teams form treatment plans. CANCER BUZZ speaks with Srdan Verstovsek, MD, PhD, Professor of Medicine & hematologist oncologist & Julie Huynh-Lu, PA-C, about MPNs & the integration of this questionnaire into the EHR. https://lnkd.in/eJG9evs8 This information is intended for US Population-Health Decision Makers or similar entities at hospitals and US oncology practices. © 2023, Incyte. MAT-HEM-03577 10/23